Key Points
- CEO John Kao sold 82,299 shares at an average price of $20.80 on April 13 for about $1.71M, trimming his stake by 4.36% to 1,806,641 shares (~$37.58M); the sale was executed under a pre-arranged Rule 10b5-1 trading plan.
- ALHC opened at $20.98 (up ~2.3%), trades in a 52-week range of $11.63–$23.87, has a market cap of $4.29B and a deeply negative P/E reflecting current losses.
- Latest quarter: EPS of −$0.05 beat estimates (−$0.15) and revenue was $1.01B (up 44.4% YoY); analysts' consensus is a "Moderate Buy" with an average price target of $24.75.
Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) CEO John Kao sold 82,299 shares of the business's stock in a transaction on Monday, April 13th. The shares were sold at an average price of $20.80, for a total transaction of $1,711,819.20. Following the completion of the transaction, the chief executive officer owned 1,806,641 shares of the company's stock, valued at approximately $37,578,132.80. This represents a 4.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Alignment Healthcare Stock Up 2.3%
ALHC opened at $20.98 on Tuesday. The company has a fifty day moving average of $19.26 and a two-hundred day moving average of $19.07. The company has a debt-to-equity ratio of 1.80, a quick ratio of 1.71 and a current ratio of 1.71. Alignment Healthcare, Inc. has a fifty-two week low of $11.63 and a fifty-two week high of $23.87. The stock has a market capitalization of $4.29 billion, a price-to-earnings ratio of -2,095.90, a PEG ratio of 3.00 and a beta of 1.20.
Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings results on Thursday, February 26th. The company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.10. The firm had revenue of $1.01 billion during the quarter, compared to analyst estimates of $1 billion. Alignment Healthcare had a negative return on equity of 0.49% and a negative net margin of 0.02%.Alignment Healthcare's revenue for the quarter was up 44.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.16) EPS. On average, research analysts expect that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.
Wall Street Analysts Forecast Growth
ALHC has been the subject of a number of research analyst reports. TD Cowen upped their price objective on shares of Alignment Healthcare from $18.50 to $25.00 and gave the stock a "buy" rating in a research report on Friday, January 16th. Robert W. Baird set a $28.00 price target on shares of Alignment Healthcare in a research note on Friday, January 30th. Weiss Ratings reissued a "sell (d-)" rating on shares of Alignment Healthcare in a report on Wednesday, January 21st. UBS Group lifted their price target on Alignment Healthcare from $18.00 to $21.00 and gave the stock a "neutral" rating in a research note on Wednesday, January 14th. Finally, KeyCorp restated an "overweight" rating and issued a $28.00 price objective on shares of Alignment Healthcare in a report on Thursday, January 22nd. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $24.75.
View Our Latest Research Report on ALHC
Hedge Funds Weigh In On Alignment Healthcare
Institutional investors have recently added to or reduced their stakes in the stock. Teacher Retirement System of Texas increased its stake in shares of Alignment Healthcare by 85.8% in the 3rd quarter. Teacher Retirement System of Texas now owns 102,827 shares of the company's stock worth $1,794,000 after acquiring an additional 47,472 shares during the last quarter. Y Intercept Hong Kong Ltd acquired a new stake in Alignment Healthcare during the third quarter worth about $3,499,000. Hudson Bay Capital Management LP purchased a new position in Alignment Healthcare during the third quarter worth about $4,581,000. Cinctive Capital Management LP acquired a new position in Alignment Healthcare in the 3rd quarter valued at about $3,814,000. Finally, Inspire Investing LLC acquired a new stake in shares of Alignment Healthcare during the 3rd quarter worth approximately $1,129,000. Hedge funds and other institutional investors own 86.19% of the company's stock.
Alignment Healthcare Company Profile
(
Get Free Report)
Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.
At the core of Alignment Healthcare's approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
